easd 2019 : declare-timi 58 - prof itamar raz
Published 5 years ago • 242 plays • Length 6:30Download video MP4
Download video MP3
Similar videos
-
7:05
aha 2018: declare timi-58- prof stephen d. wiviott
-
5:10
results declare-timi 58
-
4:06
acc 2019: declare timi 58 - dr marc p. bonaca
-
4:22
declare-timi 58 hfref | acc.19
-
5:46
cardiovascular risks reduction in diabesity-latest evidence from declare-timi 58(4)
-
10:20
easd 2019 : credence trial - prof carol pollock
-
3:32
sglt-2 in cardiovascular and kidney outcomes declare timi 58
-
1:08
declare timi 58 commentary
-
9:35
access to treatments
-
6:57
how does dapagliflozin work? understanding sglt2 inhibitors.
-
13:17
esc 2020 discussion: the dapa-ckd study — prof david wheeler & dr harriette van spall
-
6:26
ofri mosenzon, md: declare-timi 58 results
-
2:10
stephen wiviott, md: strengths and limitations of the declare-timi 58 trial
-
4:53
stephen d wiviott, md,: the dapagliflozin effect on cardiovascular events (declare-timi 58) trial
-
7:49
easd 2019 avivit cahn
-
1:55
aha 2018 | declare-timi 58
-
4:13
easd 2019 peter jacob
-
6:11
easd 2019 stephen jacob
-
5:17
expert commentary: declare-timi 58 | miles fisher
-
5:50
researcher comment: declare-timi 58 | john wilding
-
8:01
easd 2019 dragan tesic